Genovis’ subsidiary GeccoDots introduces groundbreaking product and presents pipeline project results
On September 17 GeccoDots will launch a new product intended for the preclinical market for medical imaging. The launch will occur at WMIC* in Savanna, George, USA. At the same time, new results from the Nanomotus project and the Sentinel Node project will be presented at the scientific portion of the conference.
The new product is a nanoparticle that serves as a contrast agent in magnetic resonance imaging, PET/SPECT, optical imaging and ultrasound. It is packaged in an extremely easy-to-use kit and takes less than 30 minutes to prepare. A single nanoparticle can be used in several different imaging techniques. The technology paves the way for comparative and supplementary studies using different imaging techniques, known as multimodal imaging, without needing to switch contrast agents. The product is being launched under the FeoDot Easy Label brand.
